Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 10, 2026

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Retraction Casts Doubt on Timing Effects of Immunotherapy

    Cancer Discovery
    |July 9, 2026
    PubMed
    Summary

    Despite a discredited trial, the hypothesis that circadian biology influences immunotherapy effectiveness remains viable. Researchers are re-evaluating existing evidence to determine the impact of checkpoint inhibitor dosing timing on cancer treatment outcomes.

    Related Concept Videos

    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same journal

    Brain Network Connectivity Predicts Survival in Diffuse Midline Glioma.

    Cancer discovery·2026
    Same journal

    First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts.

    Cancer discovery·2026
    Same journal

    CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma.

    Cancer discovery·2026
    Same journal

    CDK8 inhibition induces Mediator trapping and impairment of the EWSR1::FLI1 transcriptional program in Ewing sarcoma.

    Cancer discovery·2026
    Same journal

    SEZ6-Targeted ADC Shows Preliminary Efficacy in Small Cell Lung Cancer.

    Cancer discovery·2026
    Same journal

    Nonprofit Acquires Abandoned Leukemia Drug Supply.

    Cancer discovery·2026

    Area of Science:

    • Immunology
    • Oncology
    • Chronobiology

    Background:

    • A landmark randomized trial investigating checkpoint inhibitor dosing timing has been discredited.
    • This has eroded confidence in specific findings but not the underlying hypothesis.
    • The hypothesis posits that the body's natural daily rhythms (circadian biology) affect immunotherapy efficacy.

    Purpose of the Study:

    • To re-evaluate the evidence supporting the role of circadian biology in immunotherapy.
    • To determine the impact of checkpoint inhibitor dosing timing on treatment outcomes.
    • To address the controversy stemming from a discredited clinical trial.

    Main Methods:

    • Review and meta-analysis of existing preclinical and clinical data on immunotherapy timing.
    • Statistical re-analysis of previously published and unpublished data.
    • Exploration of chronotherapy principles in the context of immune checkpoint inhibitors.

    Main Results:

    • The discredited trial's specific results regarding optimal dosing timing are unreliable.
    • However, a significant body of evidence still supports the principle that circadian rhythms influence immunotherapy response.
    • Further research is needed to refine optimal dosing schedules based on chronobiology.

    Conclusions:

    • The broader hypothesis linking circadian biology to immunotherapy efficacy remains supported by surviving evidence.
    • The discredited trial necessitates a cautious re-interpretation of past results.
    • Future research should focus on establishing evidence-based chronotherapy for checkpoint inhibitors.

    Related Experiment Videos

    Last Updated: Jul 10, 2026

    Predictive Immune Modeling of Solid Tumors
    08:50

    Predictive Immune Modeling of Solid Tumors

    Published on: February 25, 2020